This inventor holds 7 USPTO granted patents. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: **Helen Elisabeth Weston: A Trailblazer in Pharmaceutical Innovation**
Introduction
Helen Elisabeth Weston is a prominent inventor based in Stevenage, Great Britain. With an impressive portfolio of seven patents, she has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments involving Factor Xa inhibitors. Her work demonstrates a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Among her notable inventions are the pyrrolidine derivatives as Factor Xa inhibitors. These innovations relate to compounds designed to ameliorate clinical conditions for which a Factor Xa inhibitor is indicated. The invention not only delineates the specific chemical formulas used but also outlines processes for their preparation and pharmaceutical compositions containing them. This work underscores her dedication to the enhancement of therapeutic strategies in medicine.
Career Highlights
Helen has worked with prestigious companies, including Glaxo Group Limited and SmithKline Beecham Corporation. Her tenure at these organizations has provided her with a rich environment for innovation and collaboration, ultimately contributing to her success as an inventor. The experience gained in these leading pharmaceutical firms has played a crucial role in shaping her career.
Collaborations
Throughout her journey, Helen collaborated with talented individuals like Chuen Chan and Julie Nicole Hamblin. These partnerships have facilitated the exchange of ideas and fostered an environment of shared innovation, enabling her to achieve her objectives in the realm of pharmaceutical inventions.
Conclusion
Helen Elisabeth Weston exemplifies the spirit of innovation in the pharmaceutical industry. With her extensive number of patents and collaborative work, she continues to impact medical science positively. Her contributions, particularly in the development of Factor Xa inhibitors, pave the way for advancements in treatment options for various clinical conditions, making her a notable figure in the realm of invention and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile